Is the Renoprotective Effect of SGLT2 Inhibitors Due to Their Beneficial Effect on Hypomagnesemia?
Journal of Diabetes & Metabolism
doi 10.4172/2155-6156.1000772
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2017
Authors
Publisher
OMICS Publishing Group